Core Scientific (CORZ) Operating Leases (2022 - 2025)

Core Scientific has disclosed Operating Leases across 4 years of filings, most recently posting $95.0 million for Q1 2025.

• Operating Leases for Q1 2025 came in at $95.0 million, up 37.57% year-over-year; the trailing twelve-month figure through Mar 2025 was $95.0 million (up 37.57% YoY), and the FY2024 annual result was $97.8 million, up 6371.1% from the prior year.
• Operating Leases came in at $95.0 million for Q1 2025 at Core Scientific, down from $97.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $97.8 million in Q4 2024 to a low of $720000.0 in Q4 2022.
• The 4-year median for Operating Leases is $33.4 million (2023), against an average of $40.5 million.
• Across the five-year window, Operating Leases soared 6442.37% in 2024 and jumped 37.57% in 2025, its largest moves.
• Core Scientific's Operating Leases stood at $720000.0 in 2022, then jumped by 110.0% to $1.5 million in 2023, then soared by 6371.1% to $97.8 million in 2024, then dropped by 2.95% to $95.0 million in 2025.
• The last three Operating Leases figures came in at $95.0 million (Q1 2025), $97.8 million (Q4 2024), and $65.3 million (Q3 2024), per Business Quant data.